Addisun Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 8.50 M
- Paid Up Capital ₹ 8.36 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
- Revenue Growth -0.75%
- Profit Growth -74.05%
- Ebitda -231.83%
- Net Worth 0.91%
- Total Assets -31.85%
About Addisun Lifesciences
Addisun Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 March 2011 and has a history of 13 years and ten months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Raksil Pharma Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.50 M and a paid-up capital of Rs 8.36 M.
The company currently has active open charges totaling ₹2.50 M.
Rajhratnaa Shilwant and Vedhika Shilwnt serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230PN2011PTC138827
-
Company No.
138827
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Mar 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
What products or services does Addisun Lifesciences Private Limited offer?
Addisun Lifesciences Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefuroxime Axetil Tablets, Antibiotic Injection, Piperacillin Tazobactam Injection, Injectable Products, Pharmaceutical Injectables, Antibacterial Drugs, Cefoperazone Sulbactam Injection, Azithromycin Tablets, Cefpodoxime Proxetil Capsules.
Who are the key members and board of directors at Addisun Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajhratnaa Shilwant
|
Director | 09-Mar-2011 | Current |
|
Vedhika Shilwnt
|
Director | 30-Dec-2020 | Current |
Financial Performance of Addisun Lifesciences.
Addisun Lifesciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.75% decrease. The company also saw a substantial fall in profitability, with a 74.05% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Addisun Lifesciences?
In 2019, Addisun Lifesciences had a promoter holding of 74.10% and a public holding of 25.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2014 | Others | ₹2.50 M | Open |
How Many Employees Work at Addisun Lifesciences?
Unlock and access historical data on people associated with Addisun Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Addisun Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Addisun Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
